BONOMI, EMANUELE MARIA
BONOMI, EMANUELE MARIA
DIPARTIMENTO DI MUSICOLOGIA E BENI CULTURALI
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial
2021-01-01 Pinto, C.; Zucali, P. A.; Pagano, M.; Grosso, F.; Pasello, G.; Garassino, M. C.; Tiseo, M.; Soto Parra, H.; Grossi, F.; Cappuzzo, F.; de Marinis, F.; Pedrazzoli, P.; Bonomi, M.; Gianoncelli, L.; Perrino, M.; Santoro, A.; Zanelli, F.; Bonelli, C.; Maconi, A.; Frega, S.; Gervasi, E.; Boni, L.; Ceresoli, G. L.
Giuseppe Verdi, «Simon Boccanegra»
2014-01-01 Powers, Harold S.; Anselm, G. e. r. h. a. r. d.; Girardi, Michele; Bonomi, EMANUELE MARIA
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis
2015-01-01 Bria, E.; Massari, F.; Maines, F.; Pilotto, S.; Bonomi, M.; Porta, C.; Bracarda, S.; Heng, D.; Santini, D.; Sperduti, I.; Giannarelli, D.; Cognetti, F.; Tortora, G.; Milella, M.
Targeted Next-Generation Sequencing Indicates a Frequent Oligogenic Involvement in Primary Ovarian Insufficiency Onset
2021-01-01 Rossetti, R.; Moleri, S.; Guizzardi, F.; Gentilini, D.; Libera, L.; Marozzi, A.; Moretti, C.; Brancati, F.; Bonomi, M.; Persani, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial | 1-gen-2021 | Pinto, C.; Zucali, P. A.; Pagano, M.; Grosso, F.; Pasello, G.; Garassino, M. C.; Tiseo, M.; Soto Parra, H.; Grossi, F.; Cappuzzo, F.; de Marinis, F.; Pedrazzoli, P.; Bonomi, M.; Gianoncelli, L.; Perrino, M.; Santoro, A.; Zanelli, F.; Bonelli, C.; Maconi, A.; Frega, S.; Gervasi, E.; Boni, L.; Ceresoli, G. L. | |
| Giuseppe Verdi, «Simon Boccanegra» | 1-gen-2014 | Powers, Harold S.; Anselm, G. e. r. h. a. r. d.; Girardi, Michele; Bonomi, EMANUELE MARIA | |
| Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis | 1-gen-2015 | Bria, E.; Massari, F.; Maines, F.; Pilotto, S.; Bonomi, M.; Porta, C.; Bracarda, S.; Heng, D.; Santini, D.; Sperduti, I.; Giannarelli, D.; Cognetti, F.; Tortora, G.; Milella, M. | |
| Targeted Next-Generation Sequencing Indicates a Frequent Oligogenic Involvement in Primary Ovarian Insufficiency Onset | 1-gen-2021 | Rossetti, R.; Moleri, S.; Guizzardi, F.; Gentilini, D.; Libera, L.; Marozzi, A.; Moretti, C.; Brancati, F.; Bonomi, M.; Persani, L. |